Magnetic resonance imaging for prostate cancer: Comparative studies including radical prostatectomy specimens and template transperineal biopsy

[1]  Tristan Barrett,et al.  Defining the learning curve for multiparametric magnetic resonance imaging (MRI) of the prostate using MRI‐transrectal ultrasonography (TRUS) fusion‐guided transperineal prostate biopsies as a validation tool , 2016, BJU international.

[2]  J. Fütterer,et al.  Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature. , 2015, European urology.

[3]  N. Lawrentschuk,et al.  Transperineal biopsy prostate cancer detection in first biopsy and repeat biopsy after negative transrectal ultrasound‐guided biopsy: the Victorian Transperineal Biopsy Collaboration experience , 2015, BJU International.

[4]  Werner Jaschke,et al.  Evaluation of the PI-RADS scoring system for mpMRI of the prostate: a whole-mount step-section analysis , 2015, World Journal of Urology.

[5]  C. Stief,et al.  Preoperative mp-MRI of the prostate provides little information about staging of prostate carcinoma in daily clinical practice , 2015, World Journal of Urology.

[6]  P. Acher,et al.  Diagnostic accuracy of magnetic resonance imaging (MRI) prostate imaging reporting and data system (PI‐RADS) scoring in a transperineal prostate biopsy setting , 2015, BJU international.

[7]  F. Fraggetta,et al.  Accuracy of 3 Tesla pelvic phased-array multiparametric MRI in diagnosing prostate cancer at repeat biopsy. , 2014, Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica.

[8]  Rajan T. Gupta,et al.  Comparing 3-T multiparametric MRI and the Partin tables to predict organ-confined prostate cancer after radical prostatectomy. , 2014, Urologic oncology.

[9]  N. Lawrentschuk,et al.  P007 Transperineal biopsy prostate cancer detection in first biopsy and post-negative TRUS biopsy settings: The Victorian transperineal biopsy collaboration experience , 2014 .

[10]  D. Moses,et al.  Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. , 2014, The Journal of urology.

[11]  F. Schröder,et al.  Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies. , 2014, European urology.

[12]  O. Rouvière,et al.  Characterization of prostate lesions as benign or malignant at multiparametric MR imaging: comparison of three scoring systems in patients treated with radical prostatectomy. , 2014, Radiology.

[13]  Evis Sala,et al.  Prostate cancer: performance characteristics of combined T2W and DW-MRI scoring in the setting of template transperineal re-biopsy using MR-TRUS fusion , 2014, European Radiology.

[14]  Shyam Natarajan,et al.  The role of magnetic resonance imaging in delineating clinically significant prostate cancer. , 2014, Urology.

[15]  Hessel Wijkstra,et al.  The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel , 2014, BJU international.

[16]  Jurgen J Fütterer,et al.  Accuracy of multiparametric MRI for prostate cancer detection: a meta-analysis. , 2014, AJR. American journal of roentgenology.

[17]  H. Ahmed,et al.  Multiparametric Magnetic Resonance Imaging in the Management and Diagnosis of Prostate Cancer: Current Applications and Strategies , 2014, Current Urology Reports.

[18]  Peter Kirkbride,et al.  Prostate cancer: summary of updated NICE guidance , 2014, BMJ : British Medical Journal.

[19]  H. Ahmed,et al.  The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level—Can it rule out clinically significant prostate cancer? , 2014, Urologic oncology.

[20]  U. Patel.  Histology core‐specific evaluation of the European Society of Urogenital Radiology (ESUR) standardised scoring system of multiparametric magnetic resonance imaging (mpMRI) of the prostate , 2013, BJU international.

[21]  L. Kiemeney,et al.  The predictive value of endorectal 3 Tesla multiparametric magnetic resonance imaging for extraprostatic extension in patients with low, intermediate and high risk prostate cancer. , 2013, The Journal of urology.

[22]  A. Rosenkrantz,et al.  3.0 T multiparametric prostate MRI using pelvic phased-array coil: utility for tumor detection prior to biopsy. , 2013, Urologic oncology.

[23]  M Emberton,et al.  Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: a paired validating cohort study using template prostate mapping biopsies as the reference standard , 2013, Prostate Cancer and Prostatic Disease.

[24]  N. Lawrentschuk,et al.  The role of magnetic resonance imaging in the diagnosis and management of prostate cancer , 2013, BJU international.

[25]  Jan van der Meulen,et al.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.

[26]  Satoru Takahashi,et al.  Efficacy of Using Three-Tesla Magnetic Resonance Imaging Diagnosis of Capsule Invasion for Decision-Making About Neurovascular Bundle Preservation in Robotic-Assisted Radical Prostatectomy , 2013, Korean journal of urology.

[27]  P. P. Iu,et al.  ESUR prostate MR guidelines. , 2013, European radiology.

[28]  Rajan T. Gupta,et al.  The state of prostate MRI in 2013. , 2013, Oncology.

[29]  N. Shah,et al.  The role of 1.5 Tesla magnetic resonance imaging in staging prostate cancer , 2013, ANZ journal of surgery.

[30]  M. Roobol,et al.  Active surveillance for low-risk prostate cancer worldwide: the PRIAS study. , 2013, European urology.

[31]  Emilie Niaf,et al.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study , 2013, European Radiology.

[32]  J. Babb,et al.  Impact of delay after biopsy and post-biopsy haemorrhage on prostate cancer tumour detection using multi-parametric MRI: a multi-reader study. , 2012, Clinical radiology.

[33]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[34]  Baris Turkbey,et al.  Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds. , 2011, The Journal of urology.

[35]  G. Haber,et al.  Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging‐targeted and systematic biopsy for significant prostate cancer detection , 2011, BJU international.

[36]  A. Wein,et al.  Campbell-Walsh Urology , 2011 .

[37]  François Cornud,et al.  Multiparametric magnetic resonance imaging for the detection and localization of prostate cancer: combination of T2‐weighted, dynamic contrast‐enhanced and diffusion‐weighted imaging , 2011, BJU international.

[38]  J. Trachtenberg,et al.  MRI for men undergoing active surveillance or with rising PSA and negative biopsies , 2010, Nature Reviews Urology.

[39]  A. Evans,et al.  ‘Prostatic evasive anterior tumours’: the role of magnetic resonance imaging , 2010, BJU international.

[40]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[41]  Mark Emberton,et al.  THE ROLE OF MAGNETIC RESONANCE IMAGING IN TARGETING PROSTATE CANCER IN PATIENTS WITH PREVIOUS NEGATIVE BIOPSIES AND ELEVATED PROSTATE‐SPECIFIC ANTIGEN LEVELS , 2009, BJU international.

[42]  Neil Fleshner,et al.  The role of magnetic resonance imaging in targeting prostate cancer in patients with previous negative biopsies and elevated prostate‐specific antigen levels , 2009, BJU international.

[43]  M. Sumura,et al.  Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer , 2008, Acta radiologica.

[44]  Jerome Marley,et al.  Campbell‐Walsh Urology, 9th Edition (E‐dition) ‐ Edited by AJ Wein, LR Kavoussi, AC Novick, AW Partin and CA Peters , 2007 .

[45]  A. Villers,et al.  Dynamic contrast enhanced, pelvic phased array magnetic resonance imaging of localized prostate cancer for predicting tumor volume: correlation with radical prostatectomy findings. , 2006, The Journal of urology.

[46]  T. Stamey,et al.  Zonal Distribution of Prostatic Adenocarcinoma: Correlation with Histologic Pattern and Direction of Spread , 1988, The American journal of surgical pathology.

[47]  Yipeng Hu,et al.  The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. , 2014, Contemporary clinical trials.

[48]  A. Rosenkrantz,et al.  Prostate imaging reporting and data system (PI-RADS): reflections on early experience with a standardized interpretation scheme for multiparametric prostate MRI. , 2014, AJR. American journal of roentgenology.

[49]  Thomas Hambrock,et al.  Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging. , 2013, Radiology.